Unity Biotechnology, Inc. Marketable Securities (Current)
Unity Biotechnology, Inc. had Marketable Securities (Current) of $8.93 million as of 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-04-22
- 2025-03-31: Marketable Securities, Current $8.93M.
- 2024-12-31: Marketable Securities, Current $15.65M.
- 2024-09-30: Marketable Securities, Current $20.14M.
- 2024-06-30: Marketable Securities, Current $26.40M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-03-31 | $8.93M 10-Q · filed 2025-04-22 |
| 2024-12-31 | $15.65M 10-Q · filed 2025-04-22 |
| 2024-09-30 | $20.14M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $26.40M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $28.90M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $23.40M 10-K · filed 2025-03-07 |
| 2023-09-30 | $38.06M 10-K · filed 2024-04-15 |
| 2023-06-30 | $49.97M 10-K · filed 2024-04-15 |
| 2023-03-31 | $60.42M 10-K · filed 2024-04-15 |
| 2022-12-31 | $82.06M 10-K · filed 2024-04-15 |
| 2022-09-30 | $76.36M 10-K · filed 2024-04-15 |
| 2022-06-30 | $45.06M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $62.72M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $55.17M 10-K · filed 2023-03-15 |
| 2021-09-30 | $58.97M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $70.44M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $73.62M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $79.89M 10-K · filed 2022-03-15 |
| 2020-09-30 | $83.63M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $72.18M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $84.18M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $84.51M 10-K · filed 2021-03-23 |
| 2019-09-30 | $76.21M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $104.89M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $115.95M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $155.74M 10-K · filed 2020-03-11 |
| 2018-09-30 | $148.92M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $151.81M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $71.28M 10-Q · filed 2018-06-07 |
| 2017-12-31 | $79.21M 10-K · filed 2019-03-06 |